JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:2117-2124, doi:10.1016/j.jacc.2004.08.053
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Hooft, C. S.
Right arrow Articles by Stricker, B. H. Ch.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Hooft, C. S.
Right arrow Articles by Stricker, B. H. Ch.

STATE-OF-THE-ART PAPER

Drug-induced atrial fibrillation

Cornelis S. van der Hooft, MD*,{ddagger}, Jan Heeringa, MD*, Gerard van Herpen, MD, PhD{dagger}, Jan A. Kors, PhD{dagger}, J. Herre Kingma, MD, PhD{ddagger},§ and Bruno H. Ch. Stricker, MB, PhD*,{ddagger},*

* Pharmaco-epidemiology Unit, Department of Epidemiology & Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands
{dagger} Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands
{ddagger} Inspectorate for Health Care, The Hague, the Netherlands
§ Department of Clinical Pharmacology, University of Groningen, Groningen, the Netherlands

Manuscript received May 28, 2004; revised manuscript received August 6, 2004, accepted August 16, 2004.

* Reprint requests and correspondence: Dr. Bruno H. Ch. Stricker, Department of Epidemiology and Biostatistics, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, the Netherlands (Email: b.stricker{at}erasmusmc.nl).

Atrial fibrillation (AF) is the most common sustained rhythm disorder observed in clinical practice and predominantly associated with cardiovascular disorders such as coronary heart disease and hypertension. However, several classes of drugs may induce AF in patients without apparent heart disease or may precipitate the onset of AF in patients with preexisting heart disease. We reviewed the literature on drug-induced AF, using the PubMed/Medline and Micromedex databases and lateral references. Successively, we discuss the potential role in the onset of AF of cardiovascular drugs, respiratory system drugs, cytostatics, central nervous system drugs, genitourinary system drugs, and some miscellaneous agents. Drug-induced AF may play a role in only a minority of the patients presenting with AF. Nevertheless, it is important to recognize drugs or other agents as a potential cause, especially in the elderly, because increasing age is associated with multiple drug use and a high incidence of AF. This may contribute to timely diagnosis and management of drug-induced AF.

Abbreviations and Acronyms
  AF = atrial fibrillation
  CABG = coronary artery bypass graft
  SLE = systemic lupus erythematosus
  SR = sinus rhythm
  SVT = supraventricular tachycardia




This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. R. Heckbert, G. Li, S. R. Cummings, N. L. Smith, and B. M. Psaty
Use of Alendronate and Risk of Incident Atrial Fibrillation in Women
Arch Intern Med, April 28, 2008; 168(8): 826 - 831.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. S. van der Hooft, J. Heeringa, G. G. Brusselle, A. Hofman, J. C. M. Witteman, J. H. Kingma, M. C. J. M. Sturkenboom, and B. H. Ch. Stricker
Corticosteroids and the risk of atrial fibrillation.
Arch Intern Med, May 8, 2006; 166(9): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-J. Chang, M.-J. Su, S.-C. Kuo, T.-P. Lin, and Y.-S. Lee
Multiple Cellular Electrophysiological Effects of a Novel Antiarrhythmic Furoquinoline Derivative HA-7 [N-Benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in Guinea Pig Cardiac Preparations
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 380 - 391.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Ogimoto, Y. Shigematsu, Y. Hara, T. Ohtsuka, T. Miki, and J. Higaki
Black Pearl in the LIFE Study: Angiotensin-II Receptor Blockade on Atrial Fibrillation for Future Personalized Medicine
J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1585 - 1585.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.